Skip to main navigation Skip to search Skip to main content

MpoxVax-AFRIVAC

Project: Standard

Project Details

StatusActive
Effective start/end date1/10/2431/03/27

Funding

  • European Developing Clinical Trials Partnership: £53,939.50